LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global neuroendocrine tumors therapeutics market is expected to post
a CAGR of close to 9% during the period 2019-2023, according to the
latest market research report by Technavio.
A key factor driving the growth of the global neuroendocrine tumors
therapeutics market is the increasing research grants and funding. Many
government and non-government organizations including companies are
striving to bring awareness about neuroendocrine tumors, which can fatal
if left untreated. Organizations are focusing on providing funding and
grants and clinical assistance for the treatment of various
neuroendocrine tumors. The purpose of this grant is to study
neuroendocrine tumors, which are commonly misdiagnosed cancer types, and
do not have adequately identified genomic drivers. Such funding programs
help in better and quicker development of therapies for the treatment of
neuroendocrine tumors.
As per Technavio, the rising awareness and strategic alliances will have
a positive impact on the market and contribute to its growth
significantly over the forecast period. This global
neuroendocrine tumors therapeutics market 2019-2023
research report also analyzes other important trends and
market drivers that will affect market growth over 2019-2023.
Global neuroendocrine tumors therapeutics
market: Rising awareness and strategic alliances
Several organizations across the world are conducting national and
international programs to increase awareness about neuroendocrine tumors
for early diagnosis of the disease. For instance, the International
Neuroendocrine Cancer Alliance (INCA) observes the neuroendocrine day on
November 10, every year. Such awareness programs also help vendors to
understand opportunities in the current market scenario and invest in
research to develop new therapies. Further, many companies are
collaborating with other organizations to develop and market treatments
and therapies to share the high cost involved in the drug development
and commercialization process. Thus, the growing number of awareness
programs and strategic alliances between brands will drive market growth
during the forecast period.
“The neuroendocrine tumors may develop anywhere in the body, such as
intestines, stomach, pancreas, and lungs, which makes diagnosis more
difficult at early stages. Although the traditional Positron emission
tomography (PET) scans are majorly used to detect cancers, they are not
an optimum effective measure in detecting malignant neuroendocrine
tumors. Thus, companies are focusing on the development of novel
diagnostic tools and methods. Techniques such as scintillography and
peptide-1 receptor imaging have been developed and used for detecting
neuroendocrine tumors. The emergence of such advances in diagnostic
techniques will positively impact market growth during the forecast
period,” says a senior research analyst at Technavio.
Global neuroendocrine tumors therapeutics
market: Segmentation analysis
This market research report segments the global neuroendocrine tumors
therapeutics market by type (somatostatin analogs, targeted therapies,
and other therapies) and geographic regions (North America, Europe,
Asia, and ROW).
The North America region led the market in 2018, followed by Europe,
Asia, and ROW respectively. The market growth in North America can be
attributed to the growing incidence of neuroendocrine tumors, increase
in research funding and grants to the diagnostic landscape and R&D
activities, and the support of insurance policies such as Medicaid and
Medicare.
Looking for more information on this market? Request
a free sample report
Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market definition
- Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
- Regional comparison
- Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Technavio
Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team
at media@technavio.com.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com